Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/02/2003US6656714 Protein for use in the immunotherapy and nutrient mixtures
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656701 Useful for treating or preventing abnormal skin conditions, diseases or disorders, for improving texture or appearance of skin, enhancing epidermal exfoliation, enhancing epidermal cell renewal
12/02/2003US6656700 Isoforms of human pregnancy-associated protein-E
12/02/2003US6656698 12832, a novel human kinase-like molecule and uses thereof
12/02/2003US6656688 Antisense modulation of NF-kappa-B p65 subunit expression
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656517 Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
12/02/2003US6656511 Removing phytate from vegetable protein with anion exchange resin, deamidation with cation exchange resin
12/02/2003US6656504 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
12/02/2003US6656499 Composition for transdermal and dermal administration of interferon-α
12/02/2003US6656490 Preventing intraocular fibrin formation; reducing inflammation
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656480 Nucleotide sequences which code polypeptide for use the treatment of mammary gland cancer
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003US6656474 Minimal adverse side effects
12/02/2003US6656473 Defatted meal from squash seeds containing protein-bound tryptophan and carbohydrate source (glucose, maltose, sucrose) for facilitating transport across the blood brain barrier; useful for inducing sleep
12/02/2003US6656471 Monitoring HLA-Cw7-restricted CTL response; AIDS prevention
12/02/2003US6656470 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates
12/02/2003US6656468 Such as botulinus antitoxin orally
12/02/2003US6656465 Antibodies that mimic actions of neurotrophins
12/02/2003US6656464 Gastric emptying-promoting composition
12/02/2003US6656462 Interleukin-1 muteins useful as vaccine adjuvants
12/02/2003US6656461 Inhibiting apoptosis of lung cells
12/02/2003US6656452 Use of inhaled NO as anti-inflammatory agent
12/02/2003US6656448 Matrix metalloproteinase inhibitors
12/02/2003US6656430 Affinity binding-based system for detecting particulates in a fluid
12/02/2003CA2172165C Human receptor h4-1bb
12/02/2003CA2161804C Purification of plasma proteins
12/02/2003CA2099268C Fusions of a viral protein and a destructive enzyme
12/02/2003CA2051562C Bacillus thuringiensis isolates active against dipteran pests
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/30/2003CA2388659A1 Phospholipase a2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease
11/30/2003CA2388456A1 Macroaggregated albumin-polyethyleneimine (maa-pei) lung-targeted delivery of respiratory syncytial virus dna vaccines
11/29/2003WO2003096988A2 Tr4/tr2 response elements
11/29/2003CA2486351A1 Tr4/tr2 response elements
11/27/2003WO2003098223A2 A method for killing cells by inhibiting histone activity in the cell
11/27/2003WO2003098220A1 Modulation of mitosis by enhancing the interaction of cdc24a and cyclinb/cdk1
11/27/2003WO2003098214A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
11/27/2003WO2003098211A1 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097857A2 Method for the detection of aquaretic compounds
11/27/2003WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097834A2 A method for in vitro molecular evolution of protein function
11/27/2003WO2003097823A1 Regulation of human serine/threonine kinase
11/27/2003WO2003097814A2 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
11/27/2003WO2003097807A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097802A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097801A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097798A2 Carotene synthase gene and uses therefor
11/27/2003WO2003097696A1 Methods and copositions for the treatment of ischemic reperfusion
11/27/2003WO2003097695A1 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
11/27/2003WO2003097694A1 Collagen and method for producing same
11/27/2003WO2003097691A1 Sodium channel regulators and modulators
11/27/2003WO2003097689A1 Obg3 fragments inhibiting the conversion of active obg3 into less active obg3 and other compositions for treatment of metabolic disorders
11/27/2003WO2003097688A2 Muteins of placental growth factor type 1, preparation method and application thereof
11/27/2003WO2003097687A2 Neuroprotective polypeptides and methods of use
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097679A1 Cystic echinococcosis protein and uses therefor
11/27/2003WO2003097677A2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
11/27/2003WO2003097671A1 Cytoplasmic transduction peptides and uses thereof
11/27/2003WO2003097670A1 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097662A1 Antisense modulation of apolipoprotein b expression
11/27/2003WO2003097107A2 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/27/2003WO2003097106A2 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097086A2 Egf receptor antagonists in the treatment of gastric cancer
11/27/2003WO2003097085A1 Ddah modulators in the treatment of pain
11/27/2003WO2003097084A1 Ddah modulators in the treatment of pain
11/27/2003WO2003097083A1 Medicinal compositions containing ghrelin
11/27/2003WO2003097081A1 Composition for treating or preventing hyperuricemia
11/27/2003WO2003097080A1 A stable aqueous composition of a peptide
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097024A1 Methods for the prevention and/or the treatment of neurological disorders
11/27/2003WO2003097012A1 Co-grinding process for the preparation of a ternary composition
11/27/2003WO2003096991A2 Amelioration of the development of cataracts and other opthalmic diseases
11/27/2003WO2003096984A2 Drug therapy for celiac sprue
11/27/2003WO2003096983A2 Method of treating dyslipidemic disorders
11/27/2003WO2003096981A2 Method of modulating angiogenesis
11/27/2003WO2003096979A2 Drug therapy for celiac sprue
11/27/2003WO2003096973A2 A direct cellular energy delivery system
11/27/2003WO2003096972A2 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
11/27/2003WO2003096967A2 Dna vaccines encoding heat shock proteins
11/27/2003WO2003096964A2 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac
11/27/2003WO2003096877A2 Prevention and treatment of streptococcal and staphylococcal infection
11/27/2003WO2003096869A2 Recombinant bet. v. 1. allergen mutants, methods and process thereof
11/27/2003WO2003083096A3 Cancer associated protein kinases and their uses
11/27/2003WO2003080638A9 Antisense iap nucleobase oligomers and uses thereof
11/27/2003WO2003079748A3 Potentiation of cancer therapies by znf217 inhibition
11/27/2003WO2003078568A3 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
11/27/2003WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
11/27/2003WO2003075841A3 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
11/27/2003WO2003074547A3 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
11/27/2003WO2003073981A3 Novel of cytokine inhibitors
1 ... 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 ... 3163